# Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED

> **NCT03950817** · PHASE4 · COMPLETED · sponsor: **Antonios Likourezos** · enrollment: 80 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg
- **DRUG:** Nebulized Sub-dissociative Dose Ketamine at 1 mg/kg
- **DRUG:** Nebulized Sub-dissociative Dose Ketamine at 1.5 mg/kg.

## Key facts

- **NCT ID:** NCT03950817
- **Lead sponsor:** Antonios Likourezos
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-13
- **Primary completion:** 2024-09-24
- **Final completion:** 2024-09-24
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950817, "Nebulized Sub-dissociative Dose Ketamine at Three Different Dosing Regimens for Treating Acute Pain in the Pediatric ED". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03950817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*